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Background 
Bloodstream infections caused by Gram-negative organisms are of 
serious concern to patients and clinicians because they may be 
acquired due to healthcare, and they pose a particular risk of being 
resistant to antibiotics. The Department of Health (NI), has 
committed to reducing healthcare-associated Gram-negative 
bloodstream infections (GNBs) by 50% by 2020. 
 
In response to this objective, during 2017/18 the Public Health 
Agency introduced a new surveillance programme for the most 
common GNB infections (Escherichia coli, Klebsiella species and 
Pseudomonas aeruginosa). 
 
Clinical microbiology laboratories reported bloodstream infections 
and patient location to PHA through a voluntary regional laboratory 
reporting system (CoSurv). We extracted data for the period 
01/01/2012 to 31/12/2016 and calculated rates using mid-year 
population estimates. Analysis was completed using R v3.4.3. 
 
 
There were 8051 cases of 
Escherichia coli, Klebsiella spp. and 
Pseudomonas aeruginosa between 
2012 and 2016 in NI 
In 2016, the highest rates 
occurred in males over the 
age of 75 
Between 2012 and 2016, 
there were 6,500 E. coli, 
1,153 Klebsiella spp and 398 
P. aeruginosa bacteraemias.  
29.3% of specimens were taken in 
Emergency departments, 57.1% were 
taken from hospital inpatients and 
13.4% were taken in Outpatient 
departments 
0.2% of specimens were 
taken by a General 
Practitioner 
 
51.7% of all reports were 
from females, 48.3% of all 
reports were from males 
 
Results 
Between 2012 and 2016, 8,051 E. coli, Klebsiella spp and P. 
aeruginosa bacteraemias were reported. Rates in Northern 
Ireland have been steadily increasing over time:  from 1,124 in 
2012 to 1,850 in 2016 (64.6% increase).  Rates were higher in 
2015 for E. coli (80.3 reports per 100,000 population) and P. 
aeruginosa (5.1 reports per 100,000 population). Rates of 
Klebsiella spp were higher in 2016 (14.4 per 100,000 population) 
(Figure 1).  
 
 
Method 
Aim 
To establish baseline data prior to implementing GNB infection 
surveillance in Northern Ireland to facilitate monitoring progress 
against this ambition in 2018/19. 
The incidence of GNB infection is rising in Northern Ireland, with 
the largest proportion being E. coli, like the rest of the UK. We 
observed regional variation in the rate of GNB although this may, 
in part, be explained by differences in case mix. We also saw an 
increased incidence in older age groups. While the majority of 
specimens are reporting during an inpatient admission it is not 
possible using existing data to explore health care association, as 
defined by DH (England) ambitions.  
 
The Public Health Agency will facilitate enhanced data collection 
(to include risk factor information such as admission dates 
devices, recent surgery and antibiotic use) to assist HSC Trusts 
with measuring change and improvement in the incidence of 
healthcare-associated Gram-negative bacteraemias. 
 
For all three organisms, the highest rates occurred in males over 
the age of 75 (with 613 reports per 100,000 population for E.coli, 
119 reports per 100,000 population for Klebsiella spp and 54 
reports per 100,000 population for P. aeruginosa) (Figure 2). 
There is some regional 
variation in rates by Trust 
geographical area. The 
highest rates of E. coli, 
Klebsiella spp and P. 
aeruginosa bacteraemias 
per 100,000 population 
were reported by the 
Belfast Trust laboratory area 
(195 reports) (Figure 3). 
Figure 3. Geographic distribution of 
Escherichia coli, Klebsiella species and 
Pseudomonas aeruginosa by Trust Laboratory  
region (Rate per 100,000 population). 
Figure 1. Rate of Escherichia coli, Klebsiella species and Pseudomonas aeruginosa per 
100,000 population in Northern Ireland 2012 – 2016. 
 
 
 
Of the specimens who had a known location recorded on CoSurv 
(6909 specimens), 927 (13.4%) had their specimen taken during 
an outpatients appointment and 12 (0.2%)  had their specimen 
taken by a general practitioner. The majority of reports had 
specimens taken during an inpatient admission episode (3947 
reports; 57.1%).  
 
 
The majority of reports are for E. coli bacteraemia (6,500 
episodes, 80.7%). 51.7% of all reports were from females, and 
48.3% of all reports were from males.  
 
Figure 2. Rate of E. coli, Klebsiella spp and P. aeruginosa per 100,000 population  by age 
group and sex.   
 
